Thrombotic Microangiopathy Medications

Yartemlea is part of the Monoclonal Antibodies class and treats Thrombotic Microangiopathy. Monoclonal antibodies are used to treat many conditions, including cancers, autoimmune diseases, and certain infections. They are similar to the antibodies in the body's immune system. But they are lab-made to have a specific target based on the condition they treat. Targets can include cancer cells, viruses, immune cells, and certain receptors in the body. Yartemlea is only available as a brand name drug.